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Abstract Renal dysfunction (RD) and venous congestion
are related and common in heart failure (HF). Studies
suggest that venous congestion may be the primary driver
of RD in HF. In this study, we sought to investigate ret-
rospectively the relationship between common measures of
renal function with caval congestion and mortality among
outpatients with HF and RD. We reviewed data from 103
HF outpatients (45 males, mean age 74 years, ejection
fraction 41.8 ± 11.6 %) with estimated glomerular filtra-
tion rate (eGFR) of\60 ml/min in a single centre. During
an ambulatory visit, all patients underwent blood test and
ultrasonography of the inferior vena cava (IVC). Caval
congestion was defined as IVC with both dilatation and
impaired collapsibility. The best values of renal metrics in
predicting caval congestion were determined with receiver-
operating characteristic analysis. The BUN/Cr ratio is
moderately correlated with IVC expiratory maximum di-
ameter (r = 0.31, p\ 0.0007). In a multiple logistic re-
gression model, BUN/Cr [25.5 (adjusted OR 2.98,
p 0.015) and eGFR B45.8 (adjusted OR 5.38, p 0.002)
identify patients at risk for caval congestion; a BUN/Cr
[23.7 was the best predictor of impaired collapsibility
(adjusted OR 4.41, p 0.001). a BUN/Cr[25.5 (HR 2.19,
95 % CI 1.21–3.94, p\ 0.001) and NYHA class 3 (HR
2.91, 95 % CI 1.60–5.31, p\ 0.0005) were independent
risk factors associated with all-cause death during a median
follow-up of 31 months. In outpatients with HF and RD, a
higher BUN/Cr and lower eGFR are reliable renal
biomarkers for caval congestion. The BUN/Cr is associated
with long-term mortality and may help to stratify HF
severity.
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Introduction
Heart failure (HF) is a major public health problem, and its
coexistence with renal dysfunction (RD) is common, and
associated with a worse outcome. Both adverse structural
and hemodynamic changes may explain this association
[1]. Renal impairment in HF was traditionally assumed to
be due to a decrease in cardiac output and a subsequent
decrease in renal perfusion [2]. However, such studies
suggest that venous congestion may be a primary driver of
HF-induced RD more so than reduced cardiac output [3,
4].The natural history of HF may include recurrent de-
compensation where congestion plays a key role leading to
HF progression and renal injury [5, 6].
Ultrasound of the inferior vena cava (IVC) and its col-
lapsibility index have been demonstrated as a quantifiable
and reliable approach for assessing volume status in HF [7,
8, 23]. This technique is aimed at identifying changes in the
respiratory pattern of the IVC, thereby providing a dynamic
metric for assessing volume status. Wide respiratory fluc-
tuations of IVC collapsibility in HF may indicate an
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intravascular depletion, whereas low values indicate a
higher probability of hemodynamic congestion, even in the
absence of clinical signs. These inferences have been
confirmed by various studies [7–10]. We hypothesized that
RD is interrelated with intra-caval volume in chronic HF.
In this study, we sought to determine the relationship be-
tween laboratory metrics of renal function and ultrasono-
graphic indices of caval congestion in outpatients with
clinically HF and RD.
Methods
Patient population
We retrospectively reviewed data of a cohort of patients
referred to the outpatient HF clinic at University Hospital
of Palermo. Study eligibility included consecutive patients
with a diagnosis of HF according to European Society of
Cardiology guidelines, [11] and concomitant RD as defined
by estimated glomerular filtration rate (eGFR)\60 ml/min
according to the Modification of Diet in Renal Disease
(MDRD) formula. To be included in the study, patients
underwent clinical history, physical examination, blood
chemistry analysis, and ultrasonography of the IVC at the
same ambulatory visit. All subjects were also evaluated
with cardiac ultrasonography. Patients hospitalized within
3 months for HF, acute coronary syndrome, cardiac tam-
ponade, pericarditis, pulmonary thromboembolism, pleu-
ropneumonia, acute renal insufficiency, pyelonephritis;
patients requiring hospitalization for decompensated HF;
patients with congenital heart disease, recipients of heart
transplantation, chronic glomerulonephritis or on renal re-
placement therapy, chronic liver disease, blood and au-
toimmune diseases, cancer, and patients or those being
treated with NSAIDs or steroids were excluded.
The study was conducted according to the Declaration
of Helsinki and was approved by the Local Medical
University Review Board. Patient records/information
were redacted and de-identified prior to analysis.
Renal function assessment
Renal function was assessed by determining the serum
creatinine, uric acid, blood urea nitrogen (BUN), and by
calculating the eGFR and BUN to creatinine ratio (BUN/
Cr). This ratio is a routinely available, inexpensive, non-
invasive marker, which may serve as a tool to stratify pa-
tients with RD (normal ratio is 10:1–20:1) and for the
differentiation of pre-renal RD from intrinsic renal
parenchymal disease. This ratio increases due to a dispro-
portionate tubular reabsorption of BUN compared to
creatinine. In HF, the BUN/Cr is elevated even when the
kidneys are functioning properly. Creatinine clearance was
determined by the four-variable MDRD formula:
186.3 9 creatinine - 1.154 9 age - 0.203 9 1.212 (if
black) 9 0.742 (if female) [12].
Inferior vena cava assessment
The IVC was used as an index of central venous pressure as
IVC measurements correlate with right atrial pressure [15].
IVC parameters were assessed by an experienced
sonographer, blinded to the aim of the study, using an ul-
trasound machine (General Electric, Milan) and images
were obtained in the semisupine position from an anterior
trans-abdominal, sub-costal approach, using an abdominal
convex probe (3–5 MHz). The transverse diameter of the
IVC was measured anterior to posterior at 2 cm from the
IVC right atrial junction with the use of electronic cal-
lipers. Measurements were taken using M-mode at max-
imum diameter during expiration (IVCED) and minimum
diameter during inspiration (IVCID). The collapse index
(CI) was calculated as the percentage of the difference
between maximum and minimum respiratory variation in
diameter divided by the maximum: (IVCED - IVCID)/
IVCED 9 100. Patients with caval congestion were de-
fined those with both increased IVCED ([2 cm) and im-
paired CI (\50 %) [16].
Follow-up
All patients were followed for a median follow-up of
31 months. The endpoint of the present follow-up investi-
gation was defined as all-cause death. Mortality data were
obtained from hospital medical records and/or telephone
interviews with the patient or relatives.
Statistical analysis
Continuous variables are summarized as mean ± standard
deviation, and categorical variables as frequency and per-
centage. Intraobserver variations for IVC measurements
were investigated using the Cohen’s kappa test. Spearman
correlation analysis and univariate linear regression ana-
lysis were used to assess the relationships between renal
metrics and ultrasonographic indexes of IVC. Differences
in the means were evaluated by an unpaired Student t test,
and the Chi squared test was applied to categorical vari-
ables. Receiver-operating characteristic (ROC) analysis
was used to evaluate the best renal metric for predicting
caval congestion. Significant univariate variables were in-
cluded in the multivariate model. Multiple logistic regres-
sion was used to assess the adjusted odds of renal metrics
for caval congestion, impaired collapsibility, and dilated
expiratory diameter of IVC. Cox proportional hazard
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regression was used to analyse the factors associated with
all-cause mortality, and hazard ratios (HR) and 95 %
confidence intervals (CI) were calculated. Kaplan–Meier
analysis was used to illustrate outcome. All statistical
analyses were performed with the Statistical Package of
Social Sciences (SPSS Version 17, SPSS Inc, Chicago, IL,
USA) and MedCalc package (Version 11.3, Belgium).
Results
Patient population
A total of 103 patients met the inclusion criteria and were
included in the analysis. Baseline characteristics of the
overall cohort are presented in Table 1. The mean age was
74.5 ± 8.5 and 58 patients (56 %) were female. NYHA
functional class of the study population ranged from II to
IV. Mean ejection fraction (EF) was 41.8 ± 11.6 % and 67
patients (65 %) had a reduced EF (\45 %). In the entire
cohort, mean values of serum creatinine, eGFR, BUN and
BUN/Cr were 1.6 ± 0.46 mg/dl, 36.8 ± 10.4 ml/min/
1.73 m2, 39.7 ± 16.5 mg/dl and 24.6 ± 8.1, respectively.
In regard to the IVC, mean values of IVCED, IVCID and
CI were 20.8 ± 6.9 mm, 11.3 ± 7.8 mm and
49.9 ± 21.5 %, respectively. Intraobserver agreement for
assessment of IVC diameters was good (k = 0.621).
The above parameters of renal function and IVC indices
were not different between patients with reduced (rEF) and
those with preserved EF (pEF).
Renal function difference according to IVC
parameters
At an univariate model, patients with reduced IVC col-
lapsibility (CI\ 50 %), in comparison to patients with
normal CI, had a significantly higher BUN/Cr (27.3 ± 9.2
vs 22.2 ± 6.2, p\ 0.001) and significantly lower eGFR
(37.8 ± 10.9 vs 42.3 ± 11.7 ml/min/1.73 m2, p\ 0.05)
(Table 2). Compared to patients with normal IVC di-
ameter, those with dilated IVC had a significantly higher
BUN (43.7 ± 18.2 vs 37 ± 14.9, p\ 0.05) and BUN/Cr
(26.7 ± 9.2 vs 23.1 ± 7, p\ 0.025) and significantly
lower eGFR (37.8 ± 10.9 vs 42.3 ± 11.7 ml/min/1.73 m2,
p\ 0.05) (Table 2). Patients with caval congestion (pres-
ence of both reduced collapsibility and dilated IVC) had a
significantly higher BUN (45.7 ± 18.7 vs 36.8 ± 14.7,
p\ 0.01) and BUN/Cr (28.2 ± 9.3 vs 22.9 ± 7.0,
p\ 0.002) and significantly lower eGFR (37.0 ± 9.8 vs
42.2 ± 12.0 ml/min/1.73 m2, p\ 0.02) in comparison to
patients with only one altered IVC parameter (Table 2).
Regarding the serum creatinine and uric acid, no significant
difference between the above groups was found, as well as
age, left ventricular EF, mean blood pressure, furosemide
dose and medications use.
Relation between renal function and caval
congestion
Between metrics of renal function, the BUN/Cr was mod-
erately and directly correlated with IVCED, suggestive of
increased intravascular volume status (r = 0.33,
p\ 0.0005), and poorly correlated with IVCID and CI,
while BUN and eGFR were weakly correlated with IVCED
(respectively, r = 0.23, p\ 0.009; r = -0.18, p\ 0.04)
and poorly correlated with IVCID and CI. Both serum
creatinine and uric acid were not correlated with any pa-
rameters of IVC. Likewise, both EF and mean blood
pressure were not correlated with any indices of IVC and
renal function. Distinguishing patients according to EF,
BUN/Cr was the only renal parameter significantly corre-
lated with IVCED in patients with preserved EF (r = 0.52,
p\ 0.0008).
Table 1 Baseline characteristics of the study cohort expressed as
mean ± standard deviations
Mean ± SD
Patients (n) 103
Age (years) 74.5 ± 8.5
Sex M/F 45/58
SBP (mmHg) 130.4 ± 19
DBP (mmHg) 77.7 ± 15.5
HR (bpm0) 78.3 ± 14.1
BUN (mg/dl) 39.7 ± 16.5
Creatinine (mg/dl) 1.6 ± 0.46
BUN/Cr 24.6 ± 8.1
eGFR (ml/min) 36.8 ± 10.4
Uric acid (mg/dl) 7.5 ± 2.8
Serum sodium (mEq/L) 140.1 ± 3.1
Haemoglobin (mg/dl) 11.5 ± 1.5
NYHA class 2 (pts) 68
NYHA class 3 (pts) 28
NYHA class 4 (pts) 7
EF (%) 41.8 ± 11.6
IVCED (mm) 20.8 ± 6.9
IVCID (mm) 11.3 ± 7.8
CI (%) 49.9 ± 21.5
Furosemide (mg) 238.6 ± 177.7
Furosemide, n (%) 95 (92)
ACEI or ARB, n (%) 90 (88)
b-blocker, n (%) 84 (82)
Digoxin, n (%) 26 (25)
Spironolactone, n (%) 31 (30)
Allopurinol, n (%) 51 (50)
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ROC curve analysis for predicting caval congestion
identified the following cutoff: BUN/Cr of 25.5 (ROC 0.64;
95 % CI 0.54–0.73, sensitivity 59 %, specificity 70.3 %),
BUN of 39.2 (ROC 0.61; 95 % CI 0.51–0.70, sensitivity
56.4 %, specificity 65.6 %) and eGFR of 45.8 (ROC 0.63;
95 % CI 0.53–0.72, sensitivity 87.2 %, specificity 46.9 %).
ROC curve analysis for predicting impaired CI identified
BUN/Cr of 23.7 (ROC 0.68; 95 % CI 0.58–0.76, sensitivity
68.1 %, specificity 71.4 %), BUN of 31.8 (ROC 0.60;
95 % CI 0.50–0.69, sensitivity 78.7 %, specificity 41.1 %)
and eGFR of 45.8 (ROC 0.55; 95 % CI 0.45–0.65, sensi-
tivity 78.7 %, specificity 44.6 %). Finally, ROC analysis
for predicting impaired dilated IVC identified BUN/Cr of
25 (ROC 0.61; 95 % CI 0.51–0.71, sensitivity 58.5 %,
specificity 66.1 %), BUN of 33.2 (ROC 0.60; 95 % CI
0.50–0.70, sensitivity 78 %, specificity 45.2 %) and eGFR
of 45.8 (ROC 0.61; 95 % CI 0.51–0.71, sensitivity 80.5 %,
specificity 43.5 %).
We performed univariate analysis and multiple logistic
regression analysis for risk of caval congestion, impaired
CI and dilated IVC including in the model only variables
found to be significant (Table 2). BUN/Cr[25.5 (adjusted
OR 2.98, p 0.015) and eGFR B45.8 (adjusted OR 5.38,
p 0.002) were independently associated with risk of caval
congestion; BUN/Cr[23.7 was the best predictor of im-
paired CI (adjusted OR 4.41, p 0.001) and eGFR B45.8
was the best predictive factor of dilated IVC (adjusted OR
2.73, p 0.037) (Table 3).
BUN/Cr and outcome
Overall, 51 patients (49.5 %) died during the follow-up
(median 31 months). The Kaplan–Meier curve for all-
cause death confirmed only BUN/Cr [25.5, other than
NYHA class (data not shown), as a parameter significantly
associated with reduced survival (Fig. 1).
By Cox time-dependent multivariate analysis including
left ventricular EF, NYHA functional class, serum sodium,
systolic blood pressure, metrics of renal function (BUN,
creatinine, eGFR, uric acid, BUN/Cr) and caval conges-
tion, we find that a BUN/Cr [25.5 (HR 2.19, 95 % CI
1.21–3.94, p\ 0.001) and NYHA class 3 (HR 2.91, 95 %
CI 1.60–5.31, p\ 0.0005) are the only independent risk
factors predicting risk of mortality.
Discussion
RD develops in approximately 50 % of HF patients with
normal renal function at the initial work-up, and it is a
strong predictor of morbidity and mortality [17, 18]. Tra-
ditionally, renal impairment in HF is assumed to be mainly
due to a decrease in cardiac output [2]. However, it is not
rare to see a progression of RD in HF patients with pre-
served systolic function or with stable EF over time. In-
deed, recent studies demonstrate that venous congestion
may be the most important hemodynamic cause leading to
RD in acute and chronic HF [19–21]. Most of these studies
were conducted in patients who underwent cardiac
catheterization for decompensated HF. Thus, the relation
between venous congestion and renal function in outpa-
tients setting remains to be verified. In this retrospective
study, we sought to investigate in outpatients with HF and
RD the relationship between routine renal metrics and non-
invasive markers for the intravascular volume status
evaluated by ultrasonography of IVC. The results show that
such metrics of renal function (BUN/Cr, BUN and eGFR)
are significantly deteriorated in patients with positive
indices for caval congestion than patients without, sug-
gesting that the worsening of the renal function may affect
congestion and vice versa. Indeed, other studies underline
that both heart and kidney worsen, in turn, the function of
Table 2 Renal metrics, expressed as mean ± standard deviations, in the study population sub-divided according to IVC parameters













Age (years) 73.8 ± 7.7 75.2 ± 8.2 NS 73.5 ± 7.8 75.8 ± 8 NS 74.1 ± 8.0 75.2 ± 7.9 NS
Sex M/F 24/32 21/26 NS 27/35 18/23 NS 28/42 17/16 NS
Creatinine (mg/dl) 1.6 ± 0.5 1.5 ± 0.3 NS 1.6 ± 0.5 1.6 ± 0.4 NS 1.6 ± 0.5 1.6 ± 0.4 NS
BUN (mg/dl) 36.9 ± 14.9 42.8 ± 17.9 NS 37 ± 14.9 43.7 ± 18.2 \0.05 36.8 ± 14.7 45.7 ± 18.7 \0.01
BUN/Cr 22.2 ± 6.2 27.3 ± 9.2 \0.001 23.1 ± 7 26.7 ± 9.2 \0.025 22.9 ± 7.0 28.2 ± 9.3 \0.002
eGFR (ml/min) 42.3 ± 11.7 37.8 ± 10.9 \0.05 42.3 ± 11.7 37.8 ± 10.9 \0.05 42.2 ± 12.0 37.0 ± 9.8 \0.02
Uric acid (mg/dl) 7 ± 2.8 8.1 ± 2.7 NS 7.6 ± 3.2 7.4 ± 2.2 NS 7.5 ± 3.1 7.6 ± 2.3 NS
EF (%) 41.8 ± 11.4 41.7 ± 12 NS 41.67 ± 11.3 41.9 ± 12.2 NS 41.4 ± 11.3 42.4 ± 12.2 NS
NYHA class 2 38 (67.9 %) 34 (72.3 %) NS 40 (64.5 %) 32 (78.0 %) NS 43 (65.2 %) 29 (78.4 %) NS
NYHA class 3 18 (32.1 %) 13 (27.7 %) 22 (35.5 %) 9 (22.0 %) 23 (34.8 %) 8 (21.6 %)
CI collapse index, IVC inferior vena cava, CC caval congestion, EF ejection fraction, NS not significance
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the other, thereby perpetuating the vicious cycle of con-
gestive HF [22].
Both renal function and congestion represent the in-
tersection between the patient’s specific clinical HF pro-
file, treatment, severity of disease, intrinsic kidney illness
and co-morbid conditions. The net amalgamation of these
characteristics is what produces the observed renal func-
tion and congestion state across populations. Thus, any
associations we find may be cause and effect from the
congestion or kidney disease [23]. In our study, multiple
logistic regression analysis indicates that BUN/Cr[25.5
and eGFR B45.8 are significantly associated with an
elevated risk for caval congestion (dilatation and impaired
collapsibility of IVC) despite their areas under ROC curve
being less than 0.70. This fact can be explained because
BUN/Cr and eGFR, although having reduced diagnostic
accuracy, are significant predicting factors for caval
congestion in a multivariate model. Thus, considering that
the primary mediator of increased venous tone is neuro-
hormonal activation, any association between renal func-
tion and caval congestion may reflect not merely
hypervolemia, but also the neurohormonal status of the
patient and the response to neurohormonal blocking
therapies. On the basis of this consideration, we can ex-
plain why BUN/Cr is a stronger biomarker of caval
congestion than eGFR. Moreover, in our study, serum
creatinine, as well as uric acid, is not related with IVC
parameters, suggesting a poor utility in predicting con-
gestion-related RD. These results may aid to clarify recent
data that reduce the prognostic role of creatinine in HF
Table 3 Relationship between
metrics of renal function and
parameters of inferior vena cava
No CC (n = 64) CC (n = 39) Crude OR (95 % CI) Adjusted OR (95 % CI) p
BUN/Cr
B25.5 45 (70.3 %) 16 (41 %) 1 1
[25.5 19 (29.7 %) 23 (59 %) 3.41 (1.48–7.84) 2.98 (1.23–7.18) 0.015
BUN (mg/dl)
B39.2 42 (65.6 %) 17 (43.6 %) 1 1
[39.2 22 (34.4 %) 22 (56.4 %) 2.47 (1.09–5.59) 0.74 (0.26–2.14) 0.6
eGFR_MDRD
[45.8 30 (46.9 %) 5 (12.8 %) 1 1
B45.8 34 (53.1 %) 34 (87.2 %) 6.00 (2.08–17.31) 5.38 (1.82–15.89) 0.002




Crude OR (95 %
CI)




B23.7 41 (73.2 %) 17 (36.2 %) 1 1
[23.7 15 (26.8 %) 30 (63.8 %) 4.82 (2.08–11.16) 4.41 (1.87–10.37) 0.001
BUN (mg/dl)
B31.8 25 (44.6 %) 12 (25.5 %) 1 1
[31.8 31 (55.45) 35 (74.5 %) 2.35 (1.01–5.45) 0.38 (0.11–1.36) 0.14
eGFR_MDRD
[45.8 25 (44.6 %) 10 (21.3 %) 1 1
B45.8 31 (55.4 %) 37 (78.7 %) 2.98 (1.24–7.16) 2.55 (1.01–6.44) 0.049




Crude OR (95 %
CI)




B25 39 (62.9 %) 16 (39.0 %) 1 1
[25 23 (37.1 %) 25 (61.0 %) 2.65 (1.18–5.97) 2.26 (0.98–5.22) 0.056
BUN (mg/dl)
B33.2 25 (40.3 %) 8 (19.5 %) 1 1
[33.2 37 (59.7 %) 33 (80.5 %) 2.79 (1.11–7.02) 1.03 (0.29–3.65) 0.9
eGFR_MDRD
[45.8 27 (43.5 %) 8 (19.5 %) 1 1
B45.8 35 (56.5 %) 33 (80.5 %) 3.18 (1.27–7.99) 2.73 (1.06–7.02) 0.037
CC caval congestion, CI collapse index, IVCED maximum expiratory diameter of inferior vena cava, OR
odds ratio
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[24] supporting the role of BUN and BUN/Cr as better
indicators of outcome [25].
Indeed, our study confirms BUN/Cr as a powerful pre-
dictor of long-term all-cause mortality in outpatients with
stable HF, while Brisco et al. find BUN/Cr associated with
a worsened survival in the setting of decompensated HF
[14]. This result may be explained by the fact that BUN/Cr
incorporates the cumulative effects of several influences,
including hemodynamic alterations resulting in renal hy-
poperfusion, and the extent of neurohormonal activation,
which is closely associated with altered renal hemody-
namics [26] and the progression of cardiac failure [27]. HF
causes arterial underfilling resulting in activation of the
sympathetic nervous system (SNS), renin–angiotensin–al-
dosterone system (RAAS) and non-osmotic arginine va-
sopressin (AVP) release [13, 28]. SNS and RAAS
activation cause increased reabsorption of sodium and
water in the proximal tubule, leading to increased proximal
tubular urea concentration in the collecting duct, with re-
sulting increased urea reabsorption [29]. Elevated AVP
levels increase urea reabsorption in the collecting duct
without creatinine reabsorption [30]. In the absence of
conditions that increase urea production, elevations in
BUN level are often determined by a decrease in
glomerular filtration rate [21]. Moreover, urea reabsorption
in proximal tubules (40–50 % of filtered urea) is passive
and is linked to the reabsorption of sodium and water [31].
Thus, the increase in sodium reabsorption in HF produces a
parallel increase in urea reabsorption. The net result is a
reduced urea excretion and an elevation in BUN level that
is not solely due to the fall in glomerular filtration rate, and,
therefore, not associated with a proportional rise in serum
creatinine level [32].
The results demonstrate that patients with higher BUN/
Cr or lower eGFR have greater risk of caval congestion,
and, for this reason, they should receive close follow-up. In
addition, patients with a higher BUN/Cr also have an in-
creased risk of mortality in the long term. Physicians
should ensure these high-risk patients receive clinical
surveillance and an optimized, evidence-based HF regimen
to reduce their risk of subsequent morbidity and mortality.
The prognostic meaning of uric acid in HF and its re-
lationship with renal worsening are well known in the lit-
erature and are similar to that of BUN. In this study, uric
acid is not associated with IVC ultrasonographic metrics or
mortality. This result might have been influenced by the
fact that 50 % of study population were in treatment with
allopurinol.
Conclusion
In conclusion, the results of this study provide evidence
that, in outpatients with HF and concomitant RD, BUN/Cr
and eGFR are routine renal metrics significantly associated
with caval congestion, defined by ultrasonography. These
Fig. 1 Kaplan–Meier analysis
for all-cause death according to
BUN/Cr
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data, thereby confirming in an ambulatory setting previous
findings regarding congestion and kidney function in HF,
suggest these parameters as surrogate biomarkers of cardio-
renal decompensation and HF-related hemodynamic and
neurohormonal alterations. Moreover, BUN/Cr, the only
renal marker associated with all-cause mortality with
NYHA class, may be considered an easily accessible tool
for stratification of HF severity in these patients. Consid-
ering the intrinsic limitations related to a single-centre
retrospective study and a small sample size, additional
investigations are required to confirm these findings, and in
order to further understand the intricate bidirectional rela-
tion occurring between renal function and venous
congestion.
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